Motzer RJ, Hutson TE, Ren M, Dutcus C, Larkin J. Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma.
Lancet Oncol 2015;
17:e4-5. [PMID:
26758760 DOI:
10.1016/s1470-2045(15)00543-4]
[Citation(s) in RCA: 95] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2015] [Revised: 11/17/2015] [Accepted: 11/18/2015] [Indexed: 01/08/2023]